ArticleFrontiers in endocrinology2025
L-shaped correlation between serum alpha-1-acid glycoprotein concentration and urinary albumin creatinine ratio in females: a cross-sectional survey.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Untargeted Urinary Proteomics Uncovers Nephroprotective and Systemic Adaptations after Obesity Surgery-Induced Weight Loss.Journal of proteome research · 2026Article
- Association between alpha-1-acid glycoprotein and frailty in US females aged 20-49 years: analysis of NHANES data (2015-2023).Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Alpha-1-acid glycoprotein (AGP) is a vital acute phase reactant that increases when glomerular filtration is impaired, making it a potential biomarker of kidney disease. The urine albumin-to-creatinine ratio (UACR) is a sensitive indicator of proteinuria and is frequently used to screen for kidney disease in its early stage. The aim of this study was to explore their correlation in order to advance our understanding of the mechanisms underlying kidney damage. Methods: This study included 2579 female participants with serum AGP and UACR from the National Health and Nutrition Examination Survey (2015-2018). We divided all participants equally into three groups based on their serum AGP concentration. The univariate and multivariate regression models were for assessing the correlation between AGP and UACR. Subgroup analyses were then performed to explore the effect of each covariate on the correlation. Smoothing splines was utilized to explore their nonlinear correlation and identify thresholds within it. Results: After adjusting for multivariate models, AGP was significantly and positively associated with UACR (p<0.0001). The study identified a specific cohort of non-Hispanic Black individuals under 20 years of age, characterized by a BMI below 25 kg/m² and a waist circumference of 80 cm or more. Within this cohort, those with hypertension and sleep disorders but without hypercholesterolemia or diabetes exhibited significantly higher UACR (p < 0.001). Furthermore, we discovered an L-shaped correlation between serum AGP concentration and UACR. Specifically, when the serum AGP concentration was less than 140 mg/dL, the UACR plateaued. Conclusions: This study is the first to address the correlation between serum AGP and UACR and found an L-shaped correlation with a threshold of 140 mg/dl. This could be a target for intervention to reduce the risk of kidney disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.